发明名称 METHOD FOR TREATING NEURODEGENERATIVE DYSFUNCTION
摘要 <p>A method of treating corticosteroid-induced cognitive impairment comprises administering an effective amount of at least one compound of formula I, or pharmaceutically acceptable salts thereof, to a subject in need of such treatment. Formula I is: wherein: A is a bridge selected from the following radicals: -(CH2)m-, -CH-CH-, -(CH2)p-O-, -(CH2)p-S-, -(CH2)p-SO2-, -(CH2)p-NR1- and -SO2-NR2-, and wherein: m is an integer of from 1 to 3 inclusive; p is an integer selected from 1 and 2; R1 is selected from the group consisting of hydrogen and C1-C5 alkyl; and R2 is C1-C5 alkyl; X and Y are independently selected from the group consisting of hydrogen and halogen; R and R' are independently selected from the group consisting of hydrogen and C1-C5 alkyl; n is an integer from 1 to 12 inclusive; and * denotes an asymmetric carbon.</p>
申请公布号 EP2299822(A2) 申请公布日期 2011.03.30
申请号 EP20090743321 申请日期 2009.04.30
申请人 TONIX PHARMACEUTICALS, INC. 发明人
分类号 A61K31/554;A01N43/42;A61K31/573;A61K45/00;A61P25/00 主分类号 A61K31/554
代理机构 代理人
主权项
地址